Cellectar Biosciences, Inc. (Nasdaq: CLRB) announces that its previously filed non-provisional US and International (PCT) patent applications for Phospholipid-Ether Analogs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE